Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11666574 Combination therapy involving diaryl macrocyclic compounds
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Current Assignee
Turning Point Therapeutics
0
Date Filed
November 25, 2020
0
Date of Patent
June 6, 2023
0
Patent Applicant
Turning Point Therapeutics
0
Patent Application Number
17104739
0
Patent Citations
US Patent 10294242 Diaryl macrocycle polymorph
0
US Patent 10246466 Diaryl macrocycles as modulators of protein kinases
0
US Patent 10316044 Chiral diaryl macrocycles as modulators of protein kinases
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11666574
0
Patent Primary Examiner
Erich A Leeser
0
CPC Code
C07D 498/18
0
A61K 31/439
0
A61K 31/4995
0
Find more entities like US Patent 11666574 Combination therapy involving diaryl macrocyclic compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE